Table 3 Pathway analysis of significantly increased genes in AD-MSCs, COPD vs control
Source | term_name | term_id | adjusted_p_value |
|---|---|---|---|
GO:MF | Extracellular matrix structural constituent | GO:0005201 | 7.89E-07 |
GO:MF | Extracellular matrix binding | GO:0050840 | 0.000773464 |
GO:MF | Extracellular matrix structural constituent conferring tensile strength | GO:0030020 | 0.011540193 |
GO:MF | Sodium channel activity | GO:0005272 | 0.012683475 |
GO:BP | Anatomical structure morphogenesis | GO:0009653 | 2.41E-11 |
GO:BP | Circulatory system development | GO:0072359 | 9.99E-08 |
GO:BP | Anatomical structure development | GO:0048856 | 2.86E-07 |
GO:BP | Multicellular organism development | GO:0007275 | 6.54E-07 |
GO:BP | Developmental process | GO:0032502 | 1.84193E-06 |
GO:BP | Forebrain development | GO:0030900 | 3.93749E-06 |